TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/30/23 08:00 | 11/29/23 | SABS | Sab Biotherapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Reich Samuel J | SD | DO | Exec CB | P | 10 | 0.8947 | 0 | 11 | 1 | 767 | D | ||||||||||||||
10/15/21 10:48 | 10/14/21 | BCYP | Big Cypress Acquisition Corp. | DE | Health | BioPrd | Biological Products, (No Diag | Reich Samuel J | FL | DOT | CEO,CFO | P | 10 | 10.11 | 0 | 1 | 0 | 3,049 | D | ||||||||||||||
1/14/21 13:33 | 1/14/21 | BCYP | Big Cypress Acquisition Corp. | DE | Financ | AcqCo | Blank Checks | Reich Samuel J | FL | DOT | CEO,CFO | P | 4,172 | 10.00 | 0 | 417 | 16 | 3,048 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |